BioArctic AB
STO:BIOA B

Watchlist Manager
BioArctic AB Logo
BioArctic AB
STO:BIOA B
Watchlist
Price: 202 SEK -5.08%
Market Cap: 17.8B SEK
Have any thoughts about
BioArctic AB?
Write Note

P/OCF
Price to OCF

-110.5
Current
-69.7
Median
21.9
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-110.5
=
Market Cap
17.9B SEK
/
Operating Cash Flow
-161.5m SEK
All Countries
Close
Market Cap P/OCF
SE
BioArctic AB
STO:BIOA B
17.9B SEK -110.5
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 690.7
US
Abbvie Inc
NYSE:ABBV
314.9B USD 19.1
US
Amgen Inc
NASDAQ:AMGN
140.6B USD 19.6
US
Gilead Sciences Inc
NASDAQ:GILD
115.7B USD 11.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.9B USD -124
US
Epizyme Inc
F:EPE
94.1B EUR -469.3
AU
CSL Ltd
ASX:CSL
135.7B AUD 30.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.8B USD 18.5
US
Seagen Inc
F:SGT
39.3B EUR -75.8
NL
argenx SE
XBRU:ARGX
36B EUR -144.4
 
SE
BioArctic AB
STO:BIOA B
Average P/OCF: 19.9
Negative Multiple: -110.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 690.7
US
Abbvie Inc
NYSE:ABBV
19.1
US
Amgen Inc
NASDAQ:AMGN
19.6
US
Gilead Sciences Inc
NASDAQ:GILD
11.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -124
US
E
Epizyme Inc
F:EPE
Negative Multiple: -469.3
AU
CSL Ltd
ASX:CSL
30.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -75.8
NL
argenx SE
XBRU:ARGX
Negative Multiple: -144.4

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More